Adage Capital Partners’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-46,343
Closed -$11.4M 1085
2022
Q3
$11.4M Sell
46,343
-1,100
-2% -$297K 0.03% 601
2022
Q2
$11.7M Sell
47,443
-100,100
-68% -$27M 0.03% 631
2022
Q1
$48.9M Sell
147,543
-25,900
-15% -$7.97M 0.09% 218
2021
Q4
$62.3M Buy
173,443
+125,100
+259% +$42.3M 0.11% 184
2021
Q3
$15.7M Buy
48,343
+29,300
+154% +$9.93M 0.03% 550
2021
Q2
$5.94M Sell
19,043
-151,200
-89% -$46.4M 0.01% 797
2021
Q1
$54.3M Buy
170,243
+20,100
+13% +$6.43M 0.11% 197
2020
Q4
$48.7M Buy
150,143
+49,830
+50% +$13.8M 0.11% 205
2020
Q3
$27.8M Sell
100,313
-76,700
-43% -$22.1M 0.07% 296
2020
Q2
$42.8M Buy
177,013
+6,101
+4% +$1.23M 0.11% 212
2020
Q1
$24.8M Buy
+170,912
New +$28.4M 0.07% 278
2019
Q3
Sell
-36,860
Closed -$9.6M 772
2019
Q2
$9.6M Sell
36,860
-19,800
-35% -$5.25M 0.02% 538
2019
Q1
$16.2M Buy
56,660
+644
+1% +$214K 0.04% 435
2018
Q4
$18.2M Buy
56,016
+21,416
+62% +$7.44M 0.05% 357
2018
Q3
$15.6M Sell
34,600
-16,800
-33% -$6.62M 0.03% 466
2018
Q2
$21M Buy
+51,400
New +$18.6M 0.05% 388
2014
Q1
Sell
-184,532
Closed -$4.93M 746
2013
Q4
$4.93M Sell
184,532
-143,568
-44% -$3.55M 0.01% 588
2013
Q3
$6.25M Sell
328,100
-200,000
-38% -$4.57M 0.02% 564
2013
Q2
$11.4M Buy
+528,100
New +$10.6M 0.04% 475

Other funds holding ABMD

Adage Capital Partners's ABMD Position: Q4 2022 in Review

Adage Capital Partners sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 46,343 shares — an estimated $11.4M sold.

Adage Capital Partners first reported a position in ABMD in Q2 2013 and held it in 19 quarters. The position peaked at $62.3M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Adage Capital Partners reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Adage Capital Partners sold 46,343 Abiomed Inc shares in Q4 2022, an estimated $11.4M.
  • Adage Capital Partners first reported a position in Abiomed Inc in Q2 2013 and held it in 19 quarters.
  • Adage Capital Partners's Abiomed Inc position peaked at $62.3M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Adage Capital Partners's 13F filing for Q4 2022, filed 14 Feb 2023.